MDS HEALTHCARE LIMITEDActive
Key figures
MDS HEALTHCARE LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £116,080.
Filed accounts2019/20–2024/25
| 2019/20 | 2023/24 | 2024/25 | |
|---|---|---|---|
| Profit for the year | — | 413,744 | -380,140 |
| Cash at bank and in hand | 1,329,492 | 517,465 | 968,713 |
| Total assets | 8,065,167 | 11,346,203 | 11,974,241 |
| Total liabilities | 4,649,209 | 4,105,931 | — |
| Net assets / total equity | 3,338,603 | 7,127,475 | 6,631,255 |
| Average number of employees | 65 | 87 | 1 |
| Average pay (per year) | — | 21,473 | 2,103,536 |
| Dividends paid | — | — | 116,080 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company is that of a dispensing chemist.
As described in the company's latest filed accounts.
Summary: MDS HEALTHCARE LIMITED
Company
MDS HEALTHCARE LIMITED is a private limited company registered with Companies House under company number 08078964. It was incorporated on 22 May 2012. Its status is active. The registered office is in Preston (PR5). Its nature of business (SIC 2007) is general medical practice activities (86210).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files full accounts. Loss for the year was £380,140. Net assets were £6,631,255, down 7% on the previous year. Cash at bank and in hand was £968,713. The company had an average of 1 employee. Figures are available for 3 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered. 4 of 7 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 5 Jun 2027.